Additionally, these abnormally expressed lncRNAs closely correlate with the occurrence, development, diagnosis, prognosis and drug resistance of RCC, such as metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) with carcinogenic effects (32, 33), differentiation and antagonist ncRNA with cancer-suppressing effects (34), NONHSAT123350 related to the long-term survival rate of patients (27). The gene discussed is MALAT1; the disease is cancer.